We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
- Authors
Schanberg, L E; Sandborg, C; Barnhart, H X; Ardoin, S P; Yow, E; Evans, G W; Mieszkalski, K L; Ilowite, N T; Eberhard, A; Imundo, L F; Kimura, Y; von Scheven, E; Silverman, E; Bowyer, S L; Punaro, M; Singer, N G; Sherry, D D; McCurdy, D; Klein-Gitelman, M; Wallace, C; Silver, R; Wagner-Weiner, L; Higgins, G C; Brunner, H I; Jung, L; Soep, J B; Reed, A M; Provenzale, J; Thompson, S D; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
- Abstract
Statins reduce atherosclerosis and cardiovascular morbidity in the general population, but their efficacy and safety in children and adolescents with systemic lupus erythematosus (SLE) are unknown. This study was undertaken to determine the 3-year efficacy and safety of atorvastatin in preventing subclinical atherosclerosis progression in pediatric-onset SLE.
- Publication
Arthritis and rheumatism, 2012, Vol 64, Issue 1, p285
- ISSN
1529-0131
- Publication type
Journal Article
- DOI
10.1002/art.30645